Mitoxantrone trial in multiple sclerosis

Lancet. 2003 Mar 29;361(9363):1133-4; author reply 1134. doi: 10.1016/S0140-6736(03)12875-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Bias
  • Disability Evaluation
  • Double-Blind Method
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Mitoxantrone / adverse effects
  • Mitoxantrone / therapeutic use*
  • Multicenter Studies as Topic
  • Multiple Sclerosis, Chronic Progressive / drug therapy*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Mitoxantrone